CELU Stock Summary and Trading Ideas (Celularity - Class A | NASDAQ:CELU)

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Celularity - Class A trades on the NASDAQ stock market under the symbol CELU.

As of October 30, 2026, CELU stock price declined to $0.80 with 163,048 million shares trading.

CELU has a beta of 1.95, meaning it tends to be more sensitive to market movements. CELU has a correlation of 0.05 to the broad based SPY ETF.

CELU has a market cap of $25.96 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CELU traded as high as $7.97 and as low as $.56.

The top ETF exchange traded funds that CELU belongs to (by Net Assets): VTI, VXF.

CELU has underperformed the market in the last year with a price return of -57.7% while the SPY ETF gained +12.3%. However, in the short term, CELU had mixed performance relative to the market. It has outperformed in the last 3 months, returning +17.7% vs +2.1% return in SPY. But in the last 2 weeks, CELU shares have been beat by the market, returning -36.0% compared to an SPY return of -1.0%.

CELU support price is $.77 and resistance is $.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELU shares will trade within this expected range on the day.